FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 171 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,016,000 | +118.2% | 53,509 | -1.5% | 0.00% | +200.0% |
Q4 2020 | $924,000 | +342.1% | 54,312 | +22.2% | 0.00% | – |
Q3 2020 | $209,000 | -33.4% | 44,459 | -13.7% | 0.00% | -100.0% |
Q2 2020 | $314,000 | +132.6% | 51,530 | -13.3% | 0.00% | – |
Q1 2020 | $135,000 | -48.9% | 59,405 | +3.4% | 0.00% | – |
Q4 2019 | $264,000 | +18.9% | 57,433 | +0.4% | 0.00% | – |
Q3 2019 | $222,000 | -30.0% | 57,190 | +8.9% | 0.00% | -100.0% |
Q2 2019 | $317,000 | -51.1% | 52,533 | +8.7% | 0.00% | 0.0% |
Q1 2019 | $648,000 | +43.4% | 48,344 | -0.6% | 0.00% | 0.0% |
Q4 2018 | $452,000 | -5.0% | 48,640 | +42.1% | 0.00% | 0.0% |
Q3 2018 | $476,000 | -10.9% | 34,228 | +1.3% | 0.00% | 0.0% |
Q2 2018 | $534,000 | -4.0% | 33,782 | +4.4% | 0.00% | 0.0% |
Q1 2018 | $556,000 | -13.9% | 32,367 | +9.7% | 0.00% | 0.0% |
Q4 2017 | $646,000 | -54.4% | 29,492 | -14.9% | 0.00% | -66.7% |
Q3 2017 | $1,418,000 | +37.4% | 34,672 | +1.1% | 0.00% | +50.0% |
Q2 2017 | $1,032,000 | -15.5% | 34,282 | +1.4% | 0.00% | -33.3% |
Q1 2017 | $1,222,000 | -25.7% | 33,798 | +3.0% | 0.00% | -25.0% |
Q4 2016 | $1,645,000 | -3.5% | 32,828 | +1.0% | 0.00% | -20.0% |
Q3 2016 | $1,705,000 | +30.6% | 32,490 | +2.9% | 0.01% | +25.0% |
Q2 2016 | $1,306,000 | +40.4% | 31,575 | +37.9% | 0.00% | +33.3% |
Q1 2016 | $930,000 | +2.5% | 22,899 | +4.8% | 0.00% | 0.0% |
Q4 2015 | $907,000 | +206.4% | 21,859 | +13.5% | 0.00% | +200.0% |
Q3 2015 | $296,000 | -35.8% | 19,259 | +3.9% | 0.00% | 0.0% |
Q2 2015 | $461,000 | +8.2% | 18,540 | -0.6% | 0.00% | 0.0% |
Q1 2015 | $426,000 | +12.7% | 18,655 | +33.2% | 0.00% | 0.0% |
Q4 2014 | $378,000 | +152.0% | 14,005 | +9.2% | 0.00% | – |
Q3 2014 | $150,000 | -24.6% | 12,820 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $199,000 | – | 12,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |